Management of Symptomatic Measles Following Exposure

Immediate Isolation and Infection Control

• The Centers for Disease Control and Prevention recommends isolating the patient immediately for at least 4 days after rash onset, as infected individuals remain contagious from 4 days before through 4 days after rash appearance 1
• All healthcare workers entering the room must wear N95 respirators or equivalent respiratory protection, regardless of immunity status 1, 2
• Only staff with presumptive evidence of immunity should provide care 1

Essential Treatment: Vitamin A Supplementation

• The World Health Organization recommends that all children with clinical measles should receive vitamin A supplementation, which reduces morbidity and mortality: 200,000 IU orally for children ≥12 months; 100,000 IU for children <12 months 3, 4, 5
• A second dose of vitamin A should be given on day 2 for complicated measles 3, 4, 5
• The American Academy of Pediatrics recommends vitamin A supplementation for eye symptoms of vitamin A deficiency, with dosing as follows: 200,000 IU oral vitamin A on day 1, 200,000 IU oral vitamin A on day 2, and 200,000 IU oral vitamin A 1-4 weeks later 3, 4

Supportive Care and Complication Management

• The Centers for Disease Control and Prevention recommends monitoring nutritional status and enrolling in feeding programs if indicated 3, 4, 5
• The World Health Organization recommends treating complications with standard therapies, including oral rehydration therapy for diarrhea and antibiotics for acute lower respiratory infection and other bacterial superinfections 3, 4, 5

Special Populations Requiring Enhanced Management

• The Centers for Disease Control and Prevention recommends that immunocompromised patients should have received immune globulin (IG) 0.5 mL/kg (maximum 15 mL) if exposed, regardless of vaccination status 6
• The American College of Obstetricians and Gynecologists recommends that pregnant women should have received IG 0.25 mL/kg (maximum 15 mL) within 6 days of exposure 7

Common Pitfalls to Avoid

• The Centers for Disease Control and Prevention recommends maintaining isolation for the full 4 days after rash onset and using N95 respirators instead of regular surgical masks 1
• The World Health Organization recommends not forgetting vitamin A supplementation, which is the only evidence-based intervention to reduce measles mortality 3, 4, 5

Vitamin A Dosing for Adults with Measles

Standard Dosing Protocol

• The Centers for Disease Control and Prevention recommends that all adults with clinical measles should receive 200,000 IU of vitamin A orally as the standard dose, provided they have not received vitamin A supplementation in the previous month 8
• The standard dose of 200,000 IU applies to all patients ≥12 months of age, including adults, according to the MMWR Recommendations and Reports 8

Repeat Dosing for Complicated Cases

• A second dose of 200,000 IU should be administered on day 2 for adults who develop complications, including pneumonia, otitis media, croup, diarrhea with dehydration, or neurological problems, as recommended by the MMWR Recommendations and Reports 8

Special Circumstances: Eye Symptoms

• If any eye symptoms of vitamin A deficiency are present, the MMWR Recommendations and Reports suggest administering an extended treatment schedule, starting with 200,000 IU oral vitamin A on day 1 8

Vitamin A Supplementation in Measles Treatment

Introduction to Vitamin A Supplementation

• The Centers for Disease Control and Prevention recommends a third dose of vitamin A (200,000 IU) should be administered 1-4 weeks after the initial two doses if the patient has any eye symptoms of vitamin A deficiency (xerosis, Bitot's spots, keratomalacia, or corneal ulceration) 9, 10

Standard Treatment Protocol

• For children ≥12 months and adults with complicated measles, the American Academy of Pediatrics recommends 200,000 IU orally on day 1, followed by 200,000 IU on day 2 9, 10
• For children <12 months with complicated measles, the World Health Organization recommends 100,000 IU (half dose) on day 1 and day 2 9, 10

Third Dose Indications

• Eye symptoms requiring a third dose of vitamin A include xerosis (dryness of the conjunctiva or cornea), Bitot's spots (foamy patches on the conjunctiva), keratomalacia (corneal softening/maceration), and corneal ulceration 9, 10, 11

Routine Follow-Up Supplementation

• The Centers for Disease Control and Prevention recommends vitamin A supplementation every 3 months as part of routine supplementation in populations at risk for vitamin A deficiency, after completing the acute measles treatment protocol 9, 10

Critical Clinical Context

• The two-dose regimen is specifically indicated for complicated measles, which includes pneumonia, otitis media, croup, diarrhea with moderate or severe dehydration, and neurological problems 9, 10
• The World Health Organization notes that toxicity is not a concern with the standard vitamin A supplementation protocol, as acute toxicity requires >300,000 IU in adults or >60,000 IU in children within hours/days 11

Measles Infection Control and Post‑Exposure Management

Isolation and Environmental Controls

• Place a patient with measles in a negative‑pressure isolation room as soon as possible to limit airborne spread. 12
• If a negative‑pressure room is unavailable, the patient should be placed in a private room with the door kept closed. 12
• Upon arrival, the patient must wear a medical‑type mask to reduce droplet dissemination. 12

Protective Equipment for Healthcare Personnel

• All staff entering the isolation room must wear N95 respirators (or equivalent), irrespective of their immunity status, because measles is transmitted via aerosols. 12
• Only personnel with presumptive evidence of measles immunity should provide direct patient care, minimizing exposure risk. 12

Contagious Period

• Individuals with measles are contagious from 4 days before rash onset until 4 days after rash onset. This defines the isolation duration and exposure window. 12

Healthcare Worker Vaccination and Work Exclusion

• Health‑care workers without documented immunity should receive the first dose of MMR vaccine immediately after exposure. 12
• Exposed staff must be excluded from work from day 5 through day 21 post‑exposure to prevent onward transmission. 12
• Workers who develop measles must remain excluded from work until at least 4 days after rash onset. 12
• Because vaccine failure occurs in ≈1 % of vaccinated individuals, all staff (including vaccinated) should use respiratory protection when caring for measles patients. 12

Post‑Exposure Prophylaxis for Contacts

• Administer the MMR vaccine within 72 hours of exposure to susceptible contacts to prevent or modify disease. 12
• For non‑immune contacts, offer intramuscular immunoglobulin (0.25 mL/kg, ≈40 mg IgG/kg) within 6 days of exposure. 12
• When immunoglobulin is given, monitor contacts for 28 days because passive antibodies can prolong the incubation period. 12

All recommendations are based on CDC (Centers for Disease Control and Prevention) guidance as published in the MMWR Recommendations and Reports (2011) – expert opinion level evidence.